Simulating Market Entry Rewards for Antibiotics Development
2018 ◽
Vol 46
(S1)
◽
pp. 32-42
◽
Keyword(s):
We design an agent based Monte Carlo model of antibiotics research and development (R&D) to explore the effects of the policy intervention known as Market Entry Reward (MER) on the likelihood that an antibiotic entering pre-clinical development reaches the market. By means of sensitivity analysis we explore the interaction between the MER and four key parameters: projected net revenues, R&D costs, venture capitalists discount rates, and large pharmaceutical organizations' financial thresholds. We show that improving revenues may be more efficient than reducing costs, and thus confirm that this pull-based policy intervention effectively stimulates antibiotics R&D.
Keyword(s):
Keyword(s):
2020 ◽
Vol 21
(2)
◽
pp. 26-37
◽
1994 ◽
Vol 24
(2)
◽
pp. 358-363
◽
2010 ◽
Vol 2
(6)
◽
pp. 549-560
◽
Keyword(s):
Keyword(s):